TITLE

An evolutionary perspective on anti-tumor immunity

AUTHOR(S)
Klinke II, David J.
PUB. DATE
January 2013
SOURCE
Frontiers in Oncology;Jan2013, Vol. 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The challenges associated with demonstrating a durable response using molecular-targeted therapies in cancer has sparked a renewed interest in viewing cancer from an evolutionary perspective. Evolutionary processes have three common traits: heterogeneity, dynamics, and a selective fitness landscape. Mutagens randomly alter the genome of host cells creating a population of cells that contain different somatic mutations. This genomic rearrangement perturbs cellular homeostasis through changing how cells interact with their tissue microenvironment. To counterbalance the ability of mutated cells to outcompete for limited resources, control structures are encoded within the cell and within the organ system, such as innate and adaptive immunity, to restore cellular homeostasis. These control structures shape the selective fitness landscape and determine whether a cell that harbors particular somatic mutations is retained or eliminated from a cell population. While next-generation sequencing has revealed the complexity and heterogeneity of oncogenic transformation, understanding the dynamics of oncogenesis and how cancer cells alter the selective fitness landscape remain unclear. In this technology review, we will summarize how recent advances in technology have impacted our understanding of these three attributes of cancer as an evolutionary process. In particular, we will focus on how advances in genome sequencing have enabled quantifying cellular heterogeneity, advances in computational power have enabled explicit testing of postulated intra- and intercellular control structures against the available data using simulation, and advances in proteomics have enabled identifying novel mechanisms of cellular cross-talk that cancer cells use to alter the fitness landscape.
ACCESSION #
88067125

 

Related Articles

  • Comparing somatic mutation-callers: beyond Venn diagrams. Su Yeon Kim; Speed, Terence P. // BMC Bioinformatics;2013, Vol. 14 Issue 1, p1 

    Background: Somatic mutation-calling based on DNA from matched tumor-normal patient samples is one of the key tasks carried by many cancer genome projects. One such large-scale project is The Cancer Genome Atlas (TCGA), which is now routinely compiling catalogs of somatic mutations from hundreds...

  • Emerging patterns of somatic mutations in cancer. Watson, Ian R.; Takahashi, Koichi; Futreal, P. Andrew; Chin, Lynda // Nature Reviews Genetics;Oct2013, Vol. 14 Issue 10, p703 

    Recent advances in technological tools for massively parallel, high-throughput sequencing of DNA have enabled the comprehensive characterization of somatic mutations in a large number of tumour samples. In this Review, we describe recent cancer genomic studies that have assembled emerging views...

  • A Race between Tumor Immunoescape and Genome Maintenance Selects for Optimum Levels of (epi)genetic Instability. Iwami, Shingo; Haeno, Hiroshi; Michor, Franziska // PLoS Computational Biology;Feb2012, Vol. 8 Issue 2, p1 

    The human immune system functions to provide continuous body-wide surveillance to detect and eliminate foreign agents such as bacteria and viruses as well as the body's own cells that undergo malignant transformation. To counteract this surveillance, tumor cells evolve mechanisms to evade...

  • Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer. Trajanoski, Zlatko; Maccalli, Cristina; Mennonna, Daniele; Casorati, Giulia; Parmiani, Giorgio; Dellabona, Paolo // Cancer Immunology, Immunotherapy;Jan2015, Vol. 64 Issue 1, p99 

    Although cancer immunotherapy shows efficacy with adoptive T cell therapy (ACT) and antibody-based immune checkpoint blockade, efficacious therapeutic vaccination of cancer patients with tumor-associated antigens (TAAs) remains largely unmet. Current cancer vaccines utilize nonmutated shared...

  • Carcinogenicity of food mutagens. Sugimura, Takashi; Nagao, Minako // Environmental Health Perspectives Supplements;May96 Supplement 3, Vol. 104, p429 

    Studies the carcinogenicity of food mutagens. Autobiotic mutagens and carcinogens; Exogenous food mutagens and carcinogens; Ordinary constituents in food acting as conditional carcinogenic factors; Heterocyclic amines; Risk of mutagens and carcinogens in food and cancer prevention.

  • Human mitochondrial DNA: roles of inherited and somatic mutations. Schon, Eric A.; DiMauro, Salvatore; Hirano, Michio // Nature Reviews Genetics;Dec2012, Vol. 13 Issue 12, p878 

    Mutations in the human mitochondrial genome are known to cause an array of diverse disorders, most of which are maternally inherited, and all of which are associated with defects in oxidative energy metabolism. It is now emerging that somatic mutations in mitochondrial DNA (mtDNA) are also...

  • Modeling tumor evolutionary dynamics. Stransky, Beatriz; de Souza, Sandro J. // Frontiers in Physiology;Feb2013, p1 

    Tumorigenesis can be seen as an evolutionary process, in which the transformation of a normal cell into a tumor cell involves a number of limiting genetic and epigenetic events, occurring in a series of discrete stages. However, not all mutations in a cell are directly involved in cancer...

  • Is systems biology a promising approach to resolve controversies in cancer research?  // Cancer Cell International;2012, Vol. 12 Issue 1, p12 

    The article offers information on system biology being a promising approach for resolving controversies in cancer research. It states that till the last decade of 20th century, biologists focused on the interior of the cell and the somatic mutation theory became dominant view in carcinogenesis....

  • Hypermutation in human cancer genomes: footprints and mechanisms. Roberts, Steven A.; Gordenin, Dmitry A. // Nature Reviews Cancer;Dec2014, Vol. 14 Issue 12, p786 

    A role for somatic mutations in carcinogenesis is well accepted, but the degree to which mutation rates influence cancer initiation and development is under continuous debate. Recently accumulated genomic data have revealed that thousands of tumour samples are riddled by hypermutation,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics